Ryan Cole
Fortuna: 2 M $ al 30/09/2026
Fortuna: 2 M $ al 30/09/2026
Mr. Ryan Cole, CPA, is a Chief Operating Officer at Tang Capital Acquisition Corp., a Chief Operating Officer at Kezar Life Sciences, Inc. and a Chief Operating Officer at Aurinia Pharmaceuticals, Inc. Mr. Cole was previously employed as a Senior Vice President-Operations by Odonate, Inc. and a Senior Auditor by Ernst & Young LLP.
He received his undergraduate degree from Santa Clara University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/05/2026 | 116.144 ( 0,09 % ) | 2 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Director de Operaciones | 23/03/2026 |
| KEZAR LIFE SCIENCES, INC. | Director de Operaciones | 11/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01/05/2012 |
| ODONATE, INC. | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.